ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

soonicorn
Last updated:

Emulate - About the company

Emulate is a series E company based in Boston (United States), founded in 2013 by and . It operates as a Developer of in vitro models for drug development. Emulate has raised $225M in funding from investors like OS Fund, and ND Capital. The company has 29 active competitors, including 14 funded and 1 that has exited. Its top competitors include companies like CN Bio, Nortis and AxoSim.

Company Details

Developer of in vitro models for drug development. The company has culture modules, organ-chips, and analytical software applications. The proprietary Organ-Chip models including the liver, intestine, kidney, and others contain tiny hollow channels lined with tens of thousands of living human cells and tissues are designed to predict human response.
Website
Social
Email ID
@emulatebio.com
Phone Number
+1
Key Metrics
Founded Year
2013
Location
Boston, United States
Stage
Series E
Total Funding
in 9 rounds
Latest Funding Round
Investors
Ranked
Employee Count
as on Dec 31, 2023
Similar Companies

Legal entities associated with Emulate

Emulate is associated with 2 legal entities given below:
Legal Entity Name
Date of incorporation
Revenue
Net Profit
Employee Count
Sep 01, 2023
-
925
763
Dec 31, 2012
-
469
260
Get your free copy of Emulate's company profile

Emulate's funding and investors

Emulate has raised a total funding of $225M over 9 rounds. Its first funding round was on Jul 28, 2014. Its latest funding round was a Series E round on Sep 07, 2021 for $82M. 2 investors participated in its latest round, which includes ATEL Capital Group, Founders Fund, CSC Upshot Ventures and Alumni Ventures.

Emulate has 24 institutional investors including OS Fund, and ND Capital. Hansjörg Wyss is only Angel Investor in Emulate.

Here is the list of recent funding rounds of Emulate:
Date of funding
Funding Amount
Round Name
Post money valuation
Revenue multiple
Investors
Sep 07, 2021
$82M
Series E
3979410
2612498
Mar 23, 2020
$19.3M
Conventional Debt
7246027
2336118
-
Aug 16, 2019
$28M
Series C
8175905
1127844
-
lockAccess funding benchmarks and valuations. Sign up today!

Emulate's founders and board of directors

The founders of Emulate are and . is the CEO of Emulate. has founded 1 more company - Sight Diagnostics.

Emulate's employee count trend

Emulate has 103 employees as of Dec 23. The total employee count is 13.2% more than what it was in Dec 22. Here is Emulate's employee count trend over the years:
Employee count trend for Emulate
lockUncover Emulate's growth story! Sign up today!

Emulate's Competitors and alternates

Top competitors of Emulate include CN Bio, Nortis and AxoSim. Here is the list of Top 10 competitors of Emulate, ranked by ÃØÃÜÑо¿Ëù score :
Overall Rank
Company Details
Short Description
Total Funding
Investors
ÃØÃÜÑо¿Ëù Score
1st
Logo for Emulate
2013, Boston (United States), Series E
Developer of in vitro models for drug development
$225M
ATEL Capital Group, Founders FundÌý&²¹³¾±è;Ìý
61/100
2nd
Logo for CN Bio
CN Bio
2009, Cambridge (United Kingdom), Series B
Develops organ-on-a-chip platforms for drug discovery
$44.8M
, Oxford University InnovationÌý&²¹³¾±è;Ìý
61/100
3rd
Logo for Nortis
Nortis
2007, Woodinville (United States), Acquired
Developer of platform for generating small segments of human tissues and organs in microfluidic chips
$10.7M
50/100
4th
Logo for AxoSim
AxoSim
2014, New Orleans (United States), Series A
Advancing nerve-on-a-chip technology to improve drug development.
$6.78M
TPG, NIHÌý&²¹³¾±è;Ìý
49/100
5th
Logo for NETRI
NETRI
2018, Lyon (France), Series A
Developer of microfluidic devices for industrial applications
$8.89M
Bpifrance, NetAngelsÌý&²¹³¾±è;Ìý
48/100
6th
Logo for Mepsgen
Mepsgen
2019, Seoul (South Korea), Series C
Developer of human organ model chips for pharmaceutical development
$29.3M
E&Investment, KB InvestmentÌý&²¹³¾±è;Ìý
47/100
7th
Logo for Obatala Sciences
Obatala Sciences
2017, New Orleans (United States), Series A
Provider of research enabling products and services to research centers
$3.53M
45/100
8th
Logo for Mimetas
Mimetas
2013, Leiden (Netherlands), Series B
Develops microfluidics-based organ-on-a-chip tissue models
$28.9M
EIC Fund, Merieux Equity PartnersÌý&²¹³¾±è;Ìý
45/100
9th
Logo for Hesperos
Hesperos
2015, Orlando (United States), Funding Raised
Developer of organ-on-a-chip solutions for preclinical testing
-
43/100
10th
Logo for Cellbox Labs
Cellbox Labs
2020, Riga (Latvia), Seed
Provider of organ-on-chip platform for drug discovery and development
$1.01M
42/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Emulate's competitors? Click to see the top ones

Emulate's Investments and acquisitions

Emulate has made no investments or acquisitions yet.

Reports related to Emulate

Here is the latest report on Emulate's sector:
View

News related to Emulate

Media has covered Emulate for 1 event in last 1 year, It was about company updates.
•
Business Wire•Sep 29, 2024•Emulate
•
PR Newswire•Oct 12, 2023•Emulate
•
Business Wire•Jun 26, 2023•Emulate
•
Tullahoma News•Mar 02, 2023•Emulate
•
Business Wire•Sep 19, 2022•Emulate
•
Business Wire•May 09, 2022•Emulate
•
Business Wire•Mar 08, 2022•Emulate
•
Business Wire•Mar 07, 2022•Fierce Biotech, Tasso, Cognito Therapeutics, Emulate
•
Business Wire•Feb 03, 2022•Emulate
•
ABFJournal•Jan 21, 2022•Alvarez & Marsal Holdings, Emulate
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

Frequently asked questions about Emulate

When was Emulate founded?
Emulate was founded in 2013.
Where is Emulate located?
Emulate is located in Boston, United States.
Is Emulate a funded company?
Emulate is a funded company, its first funding round was on Jul 28, 2014.
When was the latest funding round of Emulate?
Emulate's latest funding round was on Sep 07, 2021.
What is the annual revenue of Emulate?
Annual revenue of Emulate is undefined as on undefined.
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
  • check icon 4M+ Companies
  • check icon 212K+ Investors
  • check icon 580K+ Funding Rounds
  • check icon 207K+ Acquisitions
  • check icon 2.9K+ Sectors
  • check icon 57K+ Business Models

Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford
Are you a Founder ?
Explore our recently published companies
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long